30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Davis George Eric

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 87% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Davis George Eric's trades of Biomarin Pharmaceutical Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-26 2026-02-26
S Sale
9,614 -25.8%
18.89
US$696,186 		9,614 -25.8% 18.89 US$696,186
2026-02-26 2026-02-26
PrS Proposed sale
75,870
137.21
US$1,945,833 		75,870 137.21 US$1,945,833
2024-05-30 2024-05-28
PlS Planned sale
47,608 +4.2%
11.00
US$2,996,768 		47,608 +4.2% 11.00 US$2,996,768
2024-05-30 2024-05-28
PlS Planned sale
38,071 -39.2%
74.46
US$2,834,576 		38,071 -39.2% 74.46 US$2,834,576
2024-05-28 2024-05-28
PrS Proposed sale
40,850
75.69
US$3,091,936 		40,850 75.69 US$3,091,936
2024-05-06 2024-05-02
PlS Planned sale
1,850 -3.2%
85.01
US$157,268 		1,850 -3.2% 85.01 US$157,268
2024-05-02 2024-05-02
PrS Proposed sale
1,850
85.01
US$157,262 		1,850 85.01 US$157,262
2024-04-01 2024-03-28
PlS Planned sale
24,602 -30.6%
88.34
US$2,173,341 		24,602 -30.6% 88.34 US$2,173,341
2024-03-28 2024-03-28
PrS Proposed sale
24,602
88.34
US$2,173,341 		24,602 88.34 US$2,173,341
2023-12-14 2023-12-13
PlS Planned sale
13,764 -19.8%
95.30
US$1,311,709 		13,764 -19.8% 95.30 US$1,311,709
2023-12-13 2023-12-13
PrS Proposed sale
13,764
95.30
US$1,311,709 		13,764 95.30 US$1,311,709
2023-08-09 2023-08-08
S Sale
11,000 -13.7%
89.42
US$983,662 		11,000 -13.7% 89.42 US$983,662
2023-08-08 2023-08-08
PrS Proposed sale
11,000
89.42
US$983,662 		11,000 89.42 US$983,662
2022-08-11 2022-08-09
S Sale
47,526 -46.2%
95.93
US$4,559,169 		47,526 -46.2% 95.93 US$4,559,169
2022-08-11 2022-08-09
S Sale
3,690 -6.3%
96.34
US$355,495 		3,690 -6.3% 96.34 US$355,495
2022-07-11 2022-07-08
PlS Planned sale
7,398 -11.2%
90.00
US$665,820 		7,398 -11.2% 90.00 US$665,820
2022-05-04 2022-05-02
PlS Planned sale
15,347 -18.8%
80.38
US$1,233,592 		15,347 -18.8% 80.38 US$1,233,592
2022-03-23 2022-03-21
PlS Planned sale
6,129 -8.8%
81.29
US$498,226 		6,129 -8.8% 81.29 US$498,226
2021-05-04 2021-05-03
PlS Planned sale
2,089 -3.2%
78.30
US$163,569 		2,089 -3.2% 78.30 US$163,569
2021-05-04 2021-05-03
PlS Planned sale
2,584 -3.8%
78.30
US$202,327 		2,584 -3.8% 78.30 US$202,327
2020-05-04 2020-05-01
PlS Planned sale
12,504 -16.0%
89.38
US$1,117,608 		12,504 -16.0% 89.38 US$1,117,608
2019-11-27 2019-11-26
PlS Planned sale
3,190 -4.4%
79.66
US$254,115 		3,190 -4.4% 79.66 US$254,115
2019-03-26 2019-03-25
PlS Planned sale
3,363 -4.5%
87.86
US$295,473 		3,363 -4.5% 87.86 US$295,473
2019-03-21 2019-03-19
PlS Planned sale
7,907 -9.1%
93.92
US$742,625 		7,907 -9.1% 93.92 US$742,625